Converting to a Synchronous Virtual Nursing Research Conference Amidst a Pandemic: A Case Study

2021 ◽  
Vol 27 (2) ◽  
pp. 118-124
Author(s):  
Lilian J. Canamo ◽  
Jessica P. Bejar ◽  
Judy E. Davidson
Keyword(s):  
World Health Organization ◽  
Large Scale ◽  
University Of California ◽  
World Health ◽  
User Engagement ◽  
Research Conference ◽  
The World ◽  
Health Organization ◽  
The University

University of California San Diego Health was set to launch its 13th annual Nursing and Inquiry Innovation Conference event in June 2020. However, the Coronavirus Disease 2019 (COVID-19) pandemic placed a barrier to large gatherings throughout the world. Because the World Health Organization designated 2020 as the Year of the Nurse and Midwife, the University committed to continuing the large-scale conference, converting to a virtual event. This article reviews the methodologies behind the delivery of the virtual event and implications for user engagement and learning on the blended electronic platform.

scholarly journals COVID-19: a metaphor-based neologism and its translation into Arabic

2020 ◽  
Vol 19 (05) ◽  
pp. A01
Author(s):  
Amal Haddad Haddad ◽  
Silvia Montero-Martinez
Keyword(s):  
Mass Media ◽  
World Health Organization ◽  
World Health ◽  
The World ◽  
Official Languages ◽  
The Creation ◽  
Health Organization

‘Coronavirus Disease 2019 (COVID-19)’ is the neologism coined in reference to the pandemic disease currently affecting countries worldwide. The World Health Organization (WHO) was the international entity that coined this neologism in all its official languages, Arabic amongst them. However, in mass media, the most commonly used term is ‘coronavirus’, which is a meronymic denomination. This corpus-based case study aims at giving new insights into the creation of these neologisms in English and their equivalents in Arabic, and to the adequacy of the meronymic use of the term ‘coronavirus’ in the English and Arabic mass media.

Following the directives of World Health Organization: A Hobsons Choice

Coronaviruses ◽  
2020 ◽  
Vol 01 ◽  
Author(s):  
Shaima S. Ali Miraj
Keyword(s):  
World Health Organization ◽  
Large Scale ◽  
Financial Burden ◽  
International Health ◽  
Health Agency ◽  
Developed Countries ◽  
World Health ◽  
Effective Control ◽  
The World ◽  
Health Organization

Introduction: Of late several articles in prestigious scientific platforms have shown that, 'COVID-19 has questioned the global health expertise of some developed countries like the USA UK and other European nations as well as the international health agency, the World Health Organization, highlighting that they faltered in managing the crisis during the pandemic. The objective of this article is to highlight the fact that as there was no specific vaccine or treatment at hand, the portfolio available with these nations under the directions of the WHO to counter the measures against COVID19, was limited. There was no other alternative in this time of world’s most unprecedented emergency, and whatever immediate steps were taken to contain the virus spread by the WHO were justified. Methods: Using the available literature on the internet and library sources, a survey of published articles in leading journals of the world have been made to analyse the various articles describing the position of the WHO and its future strategies in dealing with the worlds most unprecedented pandemic. Results and Conclusion: The present communication suggests that a large scale fund allocation in a fixed percentage for Health for All, from every member country’s defence budget can be separately made for substantially replenishing the already depleting funding of the WHO. This will enable an effective control of the global pandemic crisis with significant international cooperation, allowing sharing of the financial burden. The specially created fund can be used under international monitoring for such unprecedented calamities in future. More focus can thus be given to special training of manpower, advancements in the protective equipment, development of vaccines, critical care hospitals and centres on a global basis.

World Health Organization

1949 ◽  
Vol 3 (1) ◽  
pp. 163-164
Keyword(s):  
World Health Organization ◽  
Large Scale ◽  
Venereal Disease ◽  
Western Hemisphere ◽  
World Health ◽  
Director General ◽  
Executive Board ◽  
Regional Office ◽  
The World ◽  
Health Organization

The Executive Board of the World Health Organization met in Geneva for its second session from October 25 to November 11, 1948. Some of the more important matters considered from an agenda which comprised more than seventy items included: 1) allocation of $100,000 for an extensive research program on tuberculosis; 2) approval of the report of a committee of experts on venereal disease recommending the large-scale use of penicillin in the treatment of syphilis and calling for WHO to stimulate penicillin production and distribution; 3) authorization to the WHO Director-General to create a Bureau of Medical Supplies to coordinate information and to advise governments on questions concerning the procurement of essential drugs, biological products, and medical equipment; 4) allocation of nearly $1,500,000 for the purpose of giving more direct aid to governments in all parts of the world in the form of field demonstrations and the provision of fellowships for medical and public health personnel; 5) approval of research along lines suggested by the International Congress of Mental Health, including comparative studies, surveys and demonstrations in that field; 6) appointment of Lt. Col. Chandra Mani (India) as director of the WHO Regional Office for South East Asia which was to be established early in 1949 in New Delhi, and 7) authorization to the WHO Director-General to sign a working agreement with the Pan American Sanitary Organization to serve as the WHO regional organization for the Western Hemisphere as soon as fourteen of the twenty-one American republics had completed ratification of the WHO Constitution. The next session of the Executive Board was scheduled for February 21, 1949, also in Geneva.

scholarly journals Scabies in Indonesia: Epidemiology and Prevention

2021 ◽  
Vol 1 (2) ◽  
pp. 30
Author(s):  
Reqgi First Trasia
Keyword(s):  
World Health Organization ◽  
Health Problem ◽  
Large Scale ◽  
Total Population ◽  
Preventive Measures ◽  
World Health ◽  
Neglected Tropical Disease ◽  
The World ◽  
Health Organization ◽  
Scale Control

Scabies is still a health problem in the world, including Indonesia. The World Health Organization (WHO) in 2017 stated that scabies is included in the Neglected Tropical Disease (NTD) which requires large-scale control. In Indonesia, according to data from the Ministry of Health Republic of Indonesia the prevalence of scabies in 2017 is 6% of the total population in Indonesia. Discussion on the incidence and prevention of scabies from various regions in Indonesia so far is still not comprehensive. This review will provide an overview related to epidemiology and preventive measures against scabies so that scabies cases in Indonesia can be controlled properly

scholarly journals COVID-19: an Indian perspective

2020 ◽  
Vol 7 (5) ◽  
pp. 2003
Author(s):  
Prahlad Kadambi
Keyword(s):  
Severe Acute Respiratory Syndrome ◽  
World Health Organization ◽  
Index Case ◽  
World Health ◽  
Corona Virus ◽  
First Case ◽  
The World ◽  
Health Organization ◽  
The University ◽  
Indian Perspective

Severe acute respiratory syndrome coronavirus 2 is currently spreading globally rapidly. The World Health Organization (WHO) named the virus as the 2019 novel corona virus (2019-nCoV) on January 7, 2020. On February 11th 2020, the illness associated was named as 2019 coronavirus disease (COVID-19). Subsequently, the WHO declared COVID-19 as a pandemic on 11 March 2020. The first case of COVID-19 was reported in India on 30 January 2020 in Thrissur, Kerala. This was the index case in India who tested positive after coming for a vacation. This individual was a student of the University of Wuhan. Subsequent cases were reported in Kerala. Subsequently, the number of cases in India increased to 519 as on 24th March 2020 with mortality in 7 patients as on 22nd March 2020 and 10 patients on 24th March 2020.

scholarly journals COVID-19 Vaccination Strategy in China: A Case Study

Epidemiologia ◽  
2021 ◽  
Vol 2 (3) ◽  
pp. 402-425
Author(s):  
Marjan Mohamadi ◽  
Yuling Lin ◽  
Mélissa Vuillet Soit Vulliet ◽  
Antoine Flahault ◽  
Liudmila Rozanova ◽  
...  
Keyword(s):  
World Health Organization ◽  
Infected Patient ◽  
Vaccination Strategy ◽  
World Health ◽  
Vaccination Program ◽  
The World ◽  
Important Player ◽  
Health Organization ◽  
Pharmaceutical Interventions

The coronavirus disease 2019 (COVID-19) outbreak in China was first reported to the World Health Organization on 31 December 2019, after the first cases were officially identified around 8 December 2019. However, the case of an infected patient of 55 years old can probably be traced back on 17 November. The spreading has been rapid and heterogeneous. Economic, political and social impacts have not been long overdue. This paper, based on English, French and Chinese research in national and international databases, aims to study the COVID-19 situation in China through the management of the outbreak and the Chinese response to vaccination strategy. The coronavirus disease pandemic is under control in China through non-pharmaceutical interventions, and the mass vaccination program has been launched to further prevent the disease and progressed steadily with 483.34 million doses having been administered across the country by 21 May 2021. China is also acting as an important player in the development and production of SARS-CoV-2 vaccines.

Sign in / Sign up

Export Citation Format

Share Document